Market Overview
The Global Prefilled Syringes Market is projected to reach a value of
USD 22.0 billion in 2023, and it is further projected to reach a market
value of USD 65.9 billion at an anticipated
CAGR of 13.0% in the forthcoming period of 2023 to 2032.
The global prefilled syringes market is about the business that works on making, selling, and supplying pre-loaded syringe systems. Syringes already filled with medicine are medical things that have a certain amount of medication and treatment stuff ready to use. These needles are made to make it easier to give medicines, shots, and living things like cells.
They help in being quicker, more accurate, and safer. The market has a big supply network that gives ready-to-use syringes to doctors, drugstores, and other users all around the world. This market is mainly growing because of many things like more cases of long-term health problems, the need for biologics, and focus on patient-centric healthcare delivery.
Market Dynamic
The global market for pre-filled syringes, whether they are single-use or can be used again, is greatly affected by different things. These factors change how many products are made and sold, as well as trends in the industry overall. More and more people are getting sick with long-term diseases like diabetes, arthritis, and other autoimmune conditions which leads to the need for shots to give medicine easily that's very accurate.
Easy-to-use syringes made for only one use and safely designed to meet the needs of patients needing treatment at home. The changing technology in prefilled syringe design and materials is having a big impact on the worldwide market for prefilled syringes. Also, smart syringes that can connect and have electronic parts are getting noticed. They improve how patients take their medicine and get better results. The big picture of health care, including things like telemedicine, home healthcare, and personalized medicine is changing.
This change affects the need for prefilled syringes as these fit in well with how healthcare is being given nowadays. The broader healthcare landscape, including the growing trends in telemedicine, home healthcare, and personalized medicine, influences the growth of prefilled syringes as these devices align with the increase in healthcare delivery models.
Research Scope and Analysis
By Type
Based on their type, disposable prefilled syringes dominate this segment as they hold 77.8% of the market share in 2023 and are expected to show subsequent growth in the forthcoming period of 2023 to 2032.
Disposable prefilled syringes dominate this segment as get rid of the need for cleaning and sterilization of syringes between doses as they may be meant for single use best. This function complements their convenience for healthcare professionals and patients.
Since those disposable syringes are discarded after use, the hazard of contamination or transmission of infections is substantially decreased which is enormously essential for sterile drug formulations. The disposable prefilled syringes are generally used in vaccination programs, in which mass administration of vaccines requires a quick and efficient shipping machine as their single-use design simplifies the logistics of big-scale vaccination programmes.
In addition, disposable prefilled syringes are also popular because they reduce the need for maintenance, & the associated sterilization equipment significantly reduces the cost to healthcare facilities. Additionally, the disposable nature of these syringes simplifies transportation and storage, helping to reduce overall costs in the supply chain.
By Material
In this segment, glass prefilled syringes dominate this segment as they hold the highest portion of this market, as glass is known for its inert nature, making it compatible and ideal for a wide range of drugs, including biologics and sensitive pharmaceutical formulations. This property is crucial for maintaining the stability and efficacy of the drug over time as they have low reactivity with drug substances, ensuring that the contents of the drug remain unchanged and uncontaminated during storage and administration.
Glass prefilled syringes also are geared up with tamper-obvious functions which give an additional layer of safety to these vials that make sure the integrity of the product until the factor of use. Also, some glass prefilled syringes are included with numerous protection capabilities along with retractable needles or shields to save you from needlestick accidents and enhance the overall protection of the user during and after use. Therefore, glass-prefilled syringes play a critical role within the pharmaceutical enterprise, specifically in the management of high-value and touchy drug formulations.
By Application
Based on application, diabetes dominates this segment as it holds 54.3% in 2023 and is projected to foresee subsequent growth in the forthcoming period of 2023 to 2032. Diabetes dominates this phase because prefilled syringes are broadly utilized in administering insulin to diabetic patients. The simplicity and precision of the prefilled syringes lead them to a favored preference for patients requiring everyday insulin injections to govern their diabetes degrees.
Diabetes sufferers often require common and unique dosing of insulin. Prefilled syringes do away with the need for sufferers to draw insulin from vials, simplifying the injection process and reducing the hazard of dosage errors. The premeasured doses simplify the injection procedure, making it more user-friendly and convenient for sufferers who need to self-administer insulin injections at domestic.
Additionally, prefilled syringes play a pivotal position inside the international diabetes control panorama, offering a convenient and safe solution for insulin administration. The comfort component contributes to advanced affected person compliance, as individuals with diabetes are more likely to adhere to their remedy plans when the administration is easy.
The Prefilled Syringes Market Report is segmented on the basis of the following:
By Type
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
By Material
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
By Application
- Diabetes
- Anaphylaxis
- Rheumatoid Arthritis
- Others
Regional Analysis
Europe dominates the global prefilled syringes market as it holds 40.7% of the market share in 2023 and is anticipated to show subsequent growth in the upcoming period of 2023 to 2032. Europe dominates this market because it has a properly-advanced and supportive regulatory framework, led using the European Medicines Agency (EMA) which ensures outstanding requirements, protection, and efficacy of clinical devices, together with prefilled syringes.
The streamlined approval system facilitates the rapid adoption of progressive healthcare answers. Several European countries, including Germany, France, and the UK, own superior and properly related healthcare infrastructures that facilitate the combination of prefilled syringes into scientific practices and vaccination applications for COVID-19.
Moreover, Europe has a well-developed pharmaceutical industry with leading corporations within the discipline who regularly collaborate with prefilled syringe manufacturers to increase and supply vaccines and different injectable tablets that are using the increase of the worldwide prefilled syringe marketplace. The European population is typically exceptionally fitness-conscious and has an excessive level of consciousness regarding advanced healthcare solutions which coupled with their willingness to adopt new technology, contributes to the significant popularity of prefilled syringes.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
Due to COVID-19, demand for prefilled syringes has increased sharply. As a result, the global competitive pattern in the prefilled syringes market also changed greatly. Among the established players such as BD (Becton, Dickinson and Company), Gerresheimer AG, and West Pharmaceutical Services, they have taken advantage of their production technology expertise to firmly establish themselves in this market niche which will last for years to come. Today, these leaders have adapted quickly to meet the increased demand for COVID-19 vaccination and they probably will stay dominant in this market for years ahead as well.
Additionally, start-ups based in new areas and regional companies of the same sort have also introduced new technology and materials to improve prefilled syringe performance and safety pharmacological profiles. Pharmaceutical companies and prefilled syringe manufacturers are working together more frequently. Both sides pursue end-to-end solutions as well as ensuring full compliance with regulations at every point in production.
For companies aiming to compete successfully in such an environment, concerns about regulatory compliance, production scalability, and product differentiation have become the key issues. So, the future development of the market - how it will grow, and where participants can find competitive advantages and opportunities depends on which can navigate regulatory areas while solving supply chain problems in response to emerging health-care needs.
Some of the prominent players in the Global Prefilled Syringes Market are:
- Abbott Laboratories
- Terumo Medical Corporation
- Gerresheimer AG
- Medtronic PLC
- Becton Dickinson and Company
- Nipro Corporation
- West Pharmaceuticals Services Inc.
- Bayer AG
- Vetter Pharma International GMBH
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Prefilled Syringes Market:
The COVID-19 pandemic had a big effect on the worldwide market for pre-filled syringes. The market, which was at the height of the pandemic, saw a rise in people wanting prefilled syringes. This was because they are used for COVID-19 vaccine shots. Different governments and world health groups used mass vaccination programs for big groups to stop or lower the effects of the virus. This unique plan has made the use of pre-filled syringes much higher than before. It is now a great choice for vaccinating against COVID-19.
However, supply disruptions due to lockdowns and transportation restrictions had a significant impact on the production and distribution of pre-filled syringes The economic downturn also played a role in healthcare services related to COVID-19. 19 delay or cancellation. Despite the challenges, the outbreak highlighted the importance of healthcare preparedness and presented potential growth opportunities for the pre-filled syringes market as a future healthcare enhancement part of the future healthcare infrastructure enhancements.
Report Details
| Report Characteristics |
| Market Size (2023) |
USD 22.2 Bn |
| Forecast Value (2032) |
USD 65.9 Bn |
| CAGR (2023-2032) |
13.0% |
| Historical Data |
2017 - 2022 |
| Forecast Data |
2023 - 2032 |
| Base Year |
2022 |
| Estimate Year |
2023 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Type (Disposable Prefilled Syringes and Reusable
Prefilled Syringes), By Material (Glass Prefilled
Syringes and Plastic Prefilled Syringes), By Application
(Diabetes, Anaphylaxis, Rheumatoid Arthritis and
Others) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Abbott Laboratories, Terumo Medical Corporation,
Gerresheimer AG, Medtronic PLC, Becton Dickinson
and Company, Nipro Corporation, West
Pharmaceuticals Services Inc., Bayer AG, Vetter
Pharma International GMBH, and Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Prefilled Syringes Market is expected to attain a valuation of USD 22.0 billion in 2023.
The Global Prefilled Syringes Market is expected to grow at a compound annual growth rate (CAGR) of
13.0% from 2023 to 2032.
Europe dominates the Global Prefilled Syringes Market with a revenue share of over 40.7% of the total.
Some of the prominent players in the Global Prefilled Syringes Market include Abbott Laboratories,
Terumo Medical Corporation, Gerresheimer AG, Medtronic PLC, Becton Dickinson and Company, Nipro
Corporation, West Pharmaceuticals Services Inc., Bayer AG, Vetter Pharma International GMBH and
others.